CNS Pharmaceuticals Inc
CNSP6.580USD
-0.100-1.50%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
3.78MMarket Cap
0.02P/E TTM
CNS Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-466.44
99.69%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -466.443, with a year-on-year change of 99.69%.
What is the net income of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its net income was -14.86M, with a year-on-year change of 21.18%.
What is the net margin of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 3.75%, with a year-on-year change of -78.81%.
What is the Return on Equity (ROE) of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -1703.39%, with a year-on-year change of -67.20%.
What is the Return on Assets (ROA) of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -285.68%, with a year-on-year change of -11.79%.
What is the operating profit of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -14.90M, with a year-on-year change of 21.01%.
What are the current assets of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its current assets were 8.66M, with a year-on-year change of 444.16%.
What are the total assets of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its total assets of CNS Pharmaceuticals Inc were 8.70M, with a year-on-year change of 411.56%.
What are the total liabilities of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of CNS Pharmaceuticals Inc were 2.52M, with a year-on-year change of -58.84%.
What is the total equity of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its total equity of CNS Pharmaceuticals Inc was 6.18M, with a year-on-year change of 239.36%.
What is the net operating income of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its net operating income of CNS Pharmaceuticals Inc was -14.86M, with a year-on-year change of 21.18%.
What is the net investment of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its net investment of CNS Pharmaceuticals Inc was -4.19K, with a year-on-year change of -7.36%.
What is the net financing of CNS Pharmaceuticals Inc?
According to CNS Pharmaceuticals Inc's FY2024 earnings report, its net financing of CNS Pharmaceuticals Inc was 23.03M, with a year-on-year change of 396.63%.
